The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.
Open accessAbstract
Skeletal muscle atrophy is a debilitating response to fasting, disuse, cancer, and other systemic diseases. In atrophying muscles, the ubiquitin ligase, atrogin-1 (MAFbx), is dramatically induced, and this response is necessary for rapid atrophy. Here, we show that in cultured myotubes undergoing atrophy, the activity of the PI3K/AKT pathway decreases, leading to activation of Foxo transcription factors and atrogin-1 induction. IGF-1 treatment or AKT overexpression inhibits Foxo and atrogin-1 expression. Moreover, constitutively active Foxo3 acts on the atrogin-1 promoter to cause atrogin-1 transcription and dramatic atrophy of myotubes and muscle fibers. When Foxo activation is blocked by a dominant-negative construct in myotubes or by RNAi in mouse muscles in vivo, atrogin-1 induction during starvation and atrophy of myotubes induced by glucocorticoids are prevented. Thus, forkhead factor(s) play a critical role in the development of muscle atrophy, and inhibition of Foxo factors is an attractive approach to combat muscle wasting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Two muscle-specific E3 ubiquitin ligases, muscle RING finger 1 (MuRF1, also known as TRIM63) and muscle atrophy F-Box (MAFbx, also known as atrogin-1 or FBXO32), are thought to be key regulators of proteasomal proteolysis in skeletal muscle, especially under atrophy-inducing conditions (Cai et al., 2004; Sandri et al., 2004; Stitt et al., 2004).”
From Proteasome dysfunction induces muscle growth defects and protein aggregation (2014) · cites this paper as Sandri et al., 2004
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Two muscle-specific E3 ubiquitin ligases, MuRF1 and Atrogin1, are thought to be key regulators of proteasomal proteolysis in skeletal muscle, especially under atrophy-inducing conditions (Cai et al., 2004; Sandri et al., 2004).”
From Inducible Rpt3, a Proteasome Component, Knockout in Adult Skeletal Muscle Results in Muscle Atrophy (2020) · cites this paper as Sandri et al., 2004
Experimental — accuracy not yet measuredIn the citing paper
“Atrogin-1 plays a key role in muscle atrophy as muscle specific ubiquitin ligase.”
From GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway (2023) · cites this paper as [48]
In the citing paper
“FoxO family of transcription factors (FoxO1, FoxO3, and FoxO4) are critical mediators of the catabolic response during atrophy [9, 15, 16].”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [9]
In the citing paper
“The IGF1–AKT-–mTOR axis increases protein synthesis by stimulating the translational machinery and simultaneously blocks FoxOs transcription factors and protein degradation [9].”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [9]
In the citing paper
“Alterations in mPTP function are undoubtedly contributing to the aging-related loss of muscle mass and function, since mPTP opening can trigger several atrophy-regulating pathways.”
From Mitochondrial Dynamics and Mitophagy in Skeletal Muscle Health and Aging (2021) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,295
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251541198 · Cited by 1,774
Self-citationRommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., & Glass, D. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1009 · Cited by 1,583
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., & Goldberg, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0610com · Cited by 1,539
Self-citationRubinson, D. A., Dillon, C. P., Kwiatkowski, A. V., Sievers, C., Yang, L., Kopinja, J. E., Rooney, D. L., Zhang, M., Ihrig, M. M., McManus, M. T., et al. (2003) · Nature Genetics · doi:10.1038/ng1117 · Cited by 1,499
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
Cited by
Sorted by citations
Items 701–800 of 1,032
Kazior, Z., Willis, S. J., Moberg, M., Apró, W., Calbet, J. A. L., Holmberg, H.-C., & Blomstrand, E. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149082 · Cited by 82
Choi, W. H., Son, H. J., Jang, Y. J., Ahn, J., Jung, C. H., & Ha, T. Y. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700218 · Cited by 81
Kuchay, M. S., Martínez‐Montoro, J. I., Kaur, P., Fernández‐García, J. C., & Ramos‐Molina, B. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101696 · Cited by 86
β2-Adrenergic agonists and the treatment of skeletal muscle wasting disorders
Joassard, O. R., Durieux, A., & Freyssenet, D. G. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.025 · Cited by 85
Wu, C., Kandarian, S. C., & Jackman, R. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016171 · Cited by 85
PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia
Pin, F., Novinger, L. J., Huot, J. R., Harris, R. A., Couch, M. E., O'Connell, T. M., & Bonetto, A. (2019) · The FASEB Journal · doi:10.1096/fj.201802799r · Cited by 81
Molecular regulation of skeletal muscle mass
Russell, A. P. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05265.x · Cited by 80
Ibebunjo, C., Eash, J. K., Li, C., Ma, Q., & Glass, D. J. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00402.2010 · Cited by 81
Ringseis, R., Keller, J., & Eder, K. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0511-0 · Cited by 83
Schmitt, T. L., Martignoni, M. E., Bachmann, J., Fechtner, K., Friess, H., Kinscherf, R., & Hildebrandt, W. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0177-2 · Cited by 85
Skeletal muscle mass and composition during mammalian hibernation
Cotton, C. J. (2016) · Journal of Experimental Biology · doi:10.1242/jeb.125401 · Cited by 80
Skeletal Muscle Atrophy: Discovery of Mechanisms and Potential Therapies
Ebert, S. M., Al-Zougbi, A., Bodine, S. C., & Adams, C. M. (2019) · Physiology · doi:10.1152/physiol.00003.2019 · Cited by 80
Nowell, M. M., Choi, H., & Rourke, B. C. (2010) · Journal of Comparative Physiology B · doi:10.1007/s00360-010-0505-7 · Cited by 76
Effect of Quercetin on Dexamethasone-Induced C2C12 Skeletal Muscle Cell Injury
Chen, C., Yang, J., Lu, C., Chiu, Y., Chen, H., Chung, M., Wu, Y., & Chen, F. (2020) · Molecules · doi:10.3390/molecules25143267 · Cited by 84
Léger, B., Senese, R., Al-Khodairy, A., Dériaz, O., Gobelet, C., Giacobino, J., & Russell, A. P. (2009) · Muscle & Nerve · doi:10.1002/mus.21293 · Cited by 84
Franch, H. A., Raissi, S., Wang, X., Zheng, B., Bailey, J. L., & Price, S. R. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00440.2003 · Cited by 80
Dupont, E., Cieniewski‐Bernard, C., Bastide, B., & Stevens, L. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00793.2009 · Cited by 80
Long acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents
Gurjar, A. A., Kushwaha, S., Chattopadhyay, S., Das, N., Pal, S., China, S. P., Kumar, H., Trivedi, A. K., Guha, R., Chattopadhyay, N., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2019.154044 · Cited by 79
Jaiswal, N., Gavin, M., Loro, E., Sostre‐Colón, J., Roberson, P. A., Uehara, K., Rivera‐Fuentes, N., Neinast, M., Arany, Z., Kimball, S. R., et al. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12846 · Cited by 79
Proteasome dysfunction induces muscle growth defects and protein aggregation
Kitajima, Y., Tashiro, Y., Suzuki, N., Warita, H., Kato, M., Tateyama, M., Ando, R., Izumi, R., Yamazaki, M., Abe, M., et al. (2014) · Journal of Cell Science · doi:10.1242/jcs.150961 · Cited by 79
“…finger 1 (MuRF1, also known as TRIM63) and muscle atrophy F-Box (MAFbx, also known as atrogin-1 or FBXO32), are thought to be key regulators of proteasomal proteolysis in skeletal muscle, especially under atrophy-inducing conditions (Cai et al., 2004; Sandri et al., 2004; Stitt et al., 2004).”
BackgroundWhat Causes a Broken Heart—Molecular Insights into Heart Failure
Barry, S. P., & Townsend, P. A. (2010) · International review of cytology · doi:10.1016/s1937-6448(10)84003-1 · Cited by 79
microRNAs: Modulators of the underlying pathophysiology of sarcopenia?
Brown, D. M., & Goljanek‐Whysall, K. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.08.007 · Cited by 77
Kim, J.-H., Kwak, H., Leeuwenburgh, C., & Lawler, J. M. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2007.12.012 · Cited by 83
Bruscoli, S., Donato, V., Velardi, E., Sante, M. D., Migliorati, G., Donato, R., & Riccardi, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.070136 · Cited by 85
Muscle immobilization activates mitophagy and disrupts mitochondrial dynamics in mice
Kang, C., Yeo, D., & Ji, L. L. (2016) · Acta Physiologica · doi:10.1111/apha.12690 · Cited by 81
Autophagy dysregulation in Danon disease
Nascimbeni, A. C., Fanin, M., Angelini, C. I., & Sandri, M. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.475 · Cited by 80
Self-citationNutritional strategies to counteract muscle atrophy caused by disuse and to improve recovery
Magne, H., Savary-Auzeloux, I., Rémond, D., & Dardevet, D. (2013) · Nutrition Research Reviews · doi:10.1017/s0954422413000115 · Cited by 78
Multi-dimensional Transcriptional Remodeling by Physiological Insulin In Vivo
Batista, T. M., García-Martín, R., Cai, W., Konishi, M., O'Neill, B. T., Sakaguchi, M., Kim, J. H., Jung, D. Y., Kim, J. K., & Kahn, C. R. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.081 · Cited by 76
Exogenous miR‐26a suppresses muscle wasting and renal fibrosis in obstructive kidney disease
Zhang, A., Wang, H., Wang, B., Yuan, Y., Klein, J. D., & Wang, X. H. (2019) · The FASEB Journal · doi:10.1096/fj.201900884r · Cited by 79
Haptoglobin Is Required to Prevent Oxidative Stress and Muscle Atrophy
Bertaggia, E., Scabia, G., Dalise, S., Verso, F. L., Santini, F., Vitti, P., Chisari, C., Sandri, M., & Maffei, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100745 · Cited by 79
Self-citationEffect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice
Cm, L., Yang, Z., Liu, C.-W., Wang, R., Tien, P., Dale, R., & Sun, L.-Q. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701091 · Cited by 83
“SLY AS A FOXO”: New Paths with Forkhead Signaling in the Brain
Maiese, K., Chong, Z. Z., & Shang, Y. (2007) · Current Neurovascular Research · doi:10.2174/156720207782446306 · Cited by 77
Millino, C., Fanin, M., Vettori, A., Laveder, P., Mostacciuolo, M. L., Angelini, C. I., & Lanfranchi, G. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-14 · Cited by 84
Exercise, redox homeostasis and the epigenetic landscape
Dimauro, I., Paronetto, M. P., & Caporossi, D. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101477 · Cited by 78
FoxO1 as a tissue-specific therapeutic target for type 2 diabetes
Teaney, N. A., & Cyr, N. E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1286838 · Cited by 84
Poulsen, R. C., Carr, A. J., & Hulley, P. A. (2011) · Endocrinology · doi:10.1210/en.2010-1087 · Cited by 77
Role of Autophagy in COPD Skeletal Muscle Dysfunction
Hussain, S. N. A., & Sandri, M. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00893.2012 · Cited by 77
Self-citationGalluzzo, P., Rastelli, C., Bulzomi, P., Acconcia, F., Pallottini, V., & Marino, M. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00188.2009 · Cited by 79
REDD1 Is a Major Target of Testosterone Action in Preventing Dexamethasone-Induced Muscle Loss
Wu, Y., Zhao, W., Zhao, J., Zhang, Y., Qin, W., Pan, J., Bauman, W. A., Blitzer, R. D., & Cardozo, C. P. (2009) · Endocrinology · doi:10.1210/en.2009-0530 · Cited by 81
Exercise‐mediated modulation of autophagy in skeletal muscle
Martín-Rincón, M., Morales‐Álamo, D., & Calbet, J. A. L. (2017) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.12945 · Cited by 79
Crossland, H., Skirrow, S., Puthucheary, Z., Constantin‐Teodosiu, D., & Greenhaff, P. L. (2018) · The Journal of Physiology · doi:10.1113/jp275444 · Cited by 84
Jacquemin, V., Butler-Browne, G. S., Furling, D., & Mouly, V. (2007) · Journal of Cell Science · doi:10.1242/jcs.03371 · Cited by 82
Mechanism of induction of muscle protein degradation by angiotensin II
Russell, S. T., Wyke, S. M., & Tisdale, M. J. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.09.009 · Cited by 76
Al‐Qusairi, L., Prokic, I., Amoasii, L., Kretz, C., Messaddeq, N., Mandel, J., & Laporte, J. (2013) · The FASEB Journal · doi:10.1096/fj.12-220947 · Cited by 86
McClung, J. M., McCord, T. J., Keum, S., Johnson, S., Annex, B. H., Marchuk, D. A., & Kontos, C. D. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.01.032 · Cited by 76
Tang, H., Lee, M. C., Budak, M. T., Pietras, N., Hittinger, S. A., Vu, M. D., Khuong, A., Hoang, C. D., Hussain, S. N. A., Levine, S., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-183798 · Cited by 78
A Systems Approach Identifies Essential FOXO3 Functions at Key Steps of Terminal Erythropoiesis
Liang, R. H.-S., Campreciós, G., Kou, Y., McGrath, K. E., Nowak, R. B., Catherman, S. C., Bigarella, C. L., Rimmelé, P., Zhang, X., Gnanapragasam, M. N., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005526 · Cited by 75
Network medicine, multimorbidity and the lung in the elderly
Faner, R., Cruz, T., López-Giraldo, A., & Agustí, A. G. N. (2014) · European Respiratory Journal · doi:10.1183/09031936.00078714 · Cited by 74
Activation of Akt–mTORC1 signalling reverts cancer‐dependent muscle wasting
Geremia, A., Sartori, R., Baraldo, M., Nogara, L., Balmaceda, V., Dumitras, A. G., Ciciliot, S., Scalabrin, M., Nolte, H., & Blaauw, B. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12854 · Cited by 79
VBP15: Preclinical characterization of a novel anti-inflammatory delta 9,11 steroid
Reeves, E. K. M., Hoffman, E. P., Nagaraju, K., Damsker, J. M., & McCall, J. M. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.02.009 · Cited by 75
Sankaralingam, S., Alrob, O. A., Zhang, L., Jaswal, J. S., Wagg, C. S., Fukushima, A., Padwal, R. S., Johnstone, D. E., Sharma, A. M., & Lopaschuk, G. D. (2014) · Diabetes · doi:10.2337/db14-1050 · Cited by 78
Hoffman, E. P., Riddle, V., Siegler, M. A., Dickerson, D., Bačkonja, M., Kramer, W. G., Nagaraju, K., Gordish‐Dressman, H., Damsker, J. M., & McCall, J. M. (2018) · Steroids · doi:10.1016/j.steroids.2018.02.010 · Cited by 77
Trevino, M. B., Zhang, X., Standley, R. A., Wang, M., Han, X., Reis, F. C. G., Periasamy, M., Yu, G., Kelly, D. P., Goodpaster, B. H., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00161.2019 · Cited by 73
MYTHO is a novel regulator of skeletal muscle autophagy and integrity
Leduc‐Gaudet, J., Franco‐Romero, A., Cefis, M., Moamer, A., Broering, F. E., Milan, G., Sartori, R., Chaffer, T. J., Dulac, M., Marcangeli, V., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36817-1 · Cited by 75
Self-citationAssessment of skeletal muscle proteolysis and the regulatory response to nutrition and exercise
Pasiakos, S. M., & Carbone, J. W. (2014) · IUBMB Life · doi:10.1002/iub.1291 · Cited by 79
Serra, C., Sandor, N. L., Jang, H., Lee, D. C., Toraldo, G., Guarneri, T., Wong, S., Zhang, A., Guo, W., Jasuja, R., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1004 · Cited by 75
Cassy, S., Panserat, S., Larquier, M., Dias, K., Surget, A., Plagnes‐Juan, E., Kaushik, S., & Seiliez, I. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512003352 · Cited by 74
Yakabe, M., Ogawa, S., Ota, H., Iijima, K., Eto, M., Ouchi, Y., & Akishita, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191318 · Cited by 74
Transcriptional Abnormalities of Hamstring Muscle Contractures in Children with Cerebral Palsy
Smith, L., Chambers, H. G., Subramaniam, S., & Lieber, R. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040686 · Cited by 73
Gene therapy progress and prospects: Duchenne muscular dystrophy
Foster, K., Foster, H., & Dickson, J. G. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302877 · Cited by 72
TWEAK/Fn14 Signaling Axis Mediates Skeletal Muscle Atrophy and Metabolic Dysfunction
Sato, S., Ogura, Y., & Kumar, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00018 · Cited by 74
Raffaello, A., Laveder, P., Romualdi, C., Bean, C., Toniolo, L., Germinario, E., Megighian, A., Danieli‐Betto, D., Reggiani, C., & Lanfranchi, G. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00051.2005 · Cited by 75
Álvarez-García, Ó., Matsuzaki, T., Olmer, M., Masuda, K., & Lotz, M. (2017) · Journal of Orthopaedic Research® · doi:10.1002/jor.23583 · Cited by 74
Dkk3 dependent transcriptional regulation controls age related skeletal muscle atrophy
Yin, J., Yang, L., Xie, Y., Liu, Y., Li, S., Yang, W., Xu, B., Ji, H., Ding, L., Wang, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04038-6 · Cited by 72
Irisin prevents dexamethasone-induced atrophy in C2C12 myotubes
Chang, J. S., & Kong, I. D. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02367-4 · Cited by 74
Fanzani, A., Zanola, A., Rovetta, F., Rossi, S., & Aleo, M. F. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.11.003 · Cited by 73
Palma, C. D., Morisi, F., Pambianco, S., Assi, E., Touvier, T., Russo, S., Perrotta, C., Romanello, V., Carnio, S., Cappello, V., et al. (2014) · Skeletal Muscle · doi:10.1186/s13395-014-0022-6 · Cited by 74
Self-citationCardiac ankyrin repeat protein is a marker of skeletal muscle pathological remodelling
Laure, L., Suel, L., Roudaut, C., Bourg, N., Ouali, A., Bartoli, M., Richard, I., & Danièle, N. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06814.x · Cited by 75
Docosahexaenoic Acid Prevents Palmitate-Induced Activation of Proteolytic Systems in C2C12 Myotubes
Woodworth-Hobbs, M. E., Hudson, M. B., Rahnert, J. A., Zheng, B., Franch, H. A., & Price, S. R. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.03.017 · Cited by 71
Koncarevic, A., Jackman, R. W., & Kandarian, S. C. (2007) · The FASEB Journal · doi:10.1096/fj.06-6665com · Cited by 90
Song, D. W., Ryu, J. Y., Kim, J. O., Kwon, E. J., & Kim, D. H. (2013) · Biochemical Journal · doi:10.1042/bj20130833 · Cited by 71
Shieh, J., Tseng, H., Jung, F., Yang, S., & Lin, J. (2019) · Mediators of Inflammation · doi:10.1155/2019/7947596 · Cited by 74
Is REDD1 a metabolic double agent? Lessons from physiology and pathology
Britto, F. A., Dumas, K., Giorgetti‐Peraldi, S., Ollendorff, V., & Favier, F. B. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00340.2020 · Cited by 72
Barton, P. J. R., Felkin, L. E., Birks, E. J., Cullen, M. E., Banner, N. R., Grindle, S. M., Hall, J. L., Miller, L. W., & Yacoub, M. H. (2005) · Circulation · doi:10.1161/01.circulationaha.105.525873 · Cited by 71
Differential skeletal muscle gene expression after upper or lower motor neuron transection
Zeman, R. J., Zhao, J., Zhang, Y., Zhao, W., Wen, X., Wu, Y., Pan, J., Bauman, W. A., & Cardozo, C. P. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0643-5 · Cited by 71
Zhao, W., Qin, W., Pan, J., Wu, Y., Bauman, W. A., & Cardozo, C. P. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.123 · Cited by 71
Wu, W., Zou, M., Brickley, D. R., Pew, T., & Conzen, S. D. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0131 · Cited by 71
van Langenberg, D. R., Gatta, P. A. D., Hill, B., Zacharewicz, E., Gibson, P. R., & Russell, A. P. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.11.024 · Cited by 73
Acetylation and deacetylation—novel factors in muscle wasting
Alamdari, N., Aversa, Z., Castillero, E., & Hasselgren, P.-O. J. (2012) · Metabolism · doi:10.1016/j.metabol.2012.03.019 · Cited by 71
Rajan, V., & Mitch, W. E. (2007) · Pediatric Nephrology · doi:10.1007/s00467-007-0594-z · Cited by 73
AMP-Activated Protein Kinase Regulates E3 Ligases in Rodent Heart
Baskin, K. K., & Taegtmeyer, H. (2011) · Circulation Research · doi:10.1161/circresaha.111.252742 · Cited by 71
Cullin-RING ligases in regulation of autophagy
Cui, D., Xiong, X., & Zhao, Y. (2016) · Cell Division · doi:10.1186/s13008-016-0022-5 · Cited by 74
Abmayr, S., Gregorevic, P., Allen, J. M., & Chamberlain, J. S. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.001 · Cited by 73
Stephens, N. A., Skipworth, R. J. E., Gallagher, I. J., Greig, C. A., Guttridge, D. C., Ross, J. A., & Fearon, K. C. H. (2015) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12005 · Cited by 71
Proteasome functional insufficiency in cardiac pathogenesis
Wang, X., Li, J., Zheng, H., Su, H., & Powell, S. R. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00714.2011 · Cited by 73
Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass
Cassano, M., Quattrocelli, M., Crippa, S., Perini, I., Ronzoni, F., & Sampaolesi, M. (2009) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-010-9204-y · Cited by 70
Pomiès, P., Blaquière, M., Maury, J., Mercier, J., Gouzi, F., & Hayot, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0160092 · Cited by 70
Vrahnas, C., Blank, M., Dite, T. A., Tatarczuch, L., Ansari, N., Crimeen-Irwin, B., Nguyen, H., Forwood, M. R., Hu, Y., Ikegame, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11373-9 · Cited by 70
Melnik, B. C. (2011) · Dermato-Endocrinology · doi:10.4161/derm.15331 · Cited by 94
Akt deficiency attenuates muscle size and function but not the response to ActRIIB inhibition
Goncalves, M. D., Pistilli, E. E., Balduzzi, A., Birnbaum, M. J., Lachey, J., Khurana, T. S., & Ahima, R. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012707 · Cited by 69
Urolithin B, a Newly Identified Regulator of Skeletal Muscle Mass
Rodriguez, J., Pierre, N., Naslain, D., Bontemps, F., Ferreira, D., Priem, F., Deldicque, L., & Francaux, M. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12190 · Cited by 70
Anti-TNF Treatment Reduces Rat Skeletal Muscle Wasting in Monocrotaline-Induced Cardiac Cachexia
Steffen, B. T., Lees, S. J., & Booth, F. W. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90884.2008 · Cited by 81
Massini, G., Caldiroli, L., Molinari, P., Carminati, F. M. I., Castellano, G., & Vettoretti, S. (2023) · Nutrients · doi:10.3390/nu15143107 · Cited by 70
Insulin/IGF-1 Signaling Regulates Proteasome Activity through the Deubiquitinating Enzyme UBH-4
Matilainen, O., Arpalahti, L., Rantanen, V., Hautaniemi, S., & Holmberg, C. I. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.05.012 · Cited by 70
Bone is Not Alone: the Effects of Skeletal Muscle Dysfunction in Chronic Kidney Disease
Avin, K. G., & Moorthi, R. N. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-015-0261-4 · Cited by 73
Stefanetti, R. J., Lamon, S., Wallace, M. A., Vendelbo, M. H., Russell, A. P., & Vissing, K. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1587-y · Cited by 71
Rudolf, R., Bogomolovas, J., Strack, S., Choi, K. R., Khan, M. M., Wagner, A., Brohm, K., Hanashima, A., Gasch, A., Labeit, D., et al. (2012) · AGE · doi:10.1007/s11357-012-9468-9 · Cited by 71
Comparative assessment of the quadriceps and the diaphragm in patients with COPD
Caron, M., Debigaré, R., Dekhuijzen, P. N. R., & Maltais, F. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00194.2009 · Cited by 69
Ciarapica, R., Salvo, M. D., Carcarino, E., Bracaglia, G., Adesso, L., Leoncini, P. P., Dall’Agnese, A., Walters, Z. S., Verginelli, F., Sio, L. D., et al. (2013) · Oncogene · doi:10.1038/onc.2013.471 · Cited by 70
Sugita, S., Fleming, L. L., Wood, C., Doss, S. V., Gomes, M. P. S. M., de Camargo, W. L., Naves, L. A., Prado, V. F., Prado, M. A. M., Guatimosim, C., et al. (2016) · Skeletal Muscle · doi:10.1186/s13395-016-0105-7 · Cited by 69
Metadata
- Authors
- Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L.
- Affiliations
- Harvard University (US)
- Veneto Institute of Molecular Medicine (IT)
- Beth Israel Deaconess Medical Center (US)
- Boston University (US)
- Corresponding author
- Lecker, Stewart H
- Goldberg, Alfred L
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 117
- Issue
- 3
- Pages
- 399-412
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC3619734
- OpenAlex
- W2033797333
- Cited by
- 3,012
- References
- 41
- Citations by year
- 2026: 129 · 2025: 122 · 2024: 121 · 2023: 118 · 2022: 141 · 2021: 153 · 2020: 165 · 2019: 159 · 2018: 151 · 2017: 117 · 2016: 134 · 2015: 171 · 2014: 176 · 2013: 177 · 2012: 150
- FWCI
- 33.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- National Space Biomedical Research Institute
- European Commission (QLRT-2000-00530)
- National Institutes of Health (DK02707, DK62307)
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Agenzia Spaziale Italiana
- Muscular Dystrophy Association
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- FOXO transcription factors, atrogin-1, skeletal muscle atrophy, ubiquitin ligase, PI3K/Akt signaling, insulin-like growth factor I, FOXO3, forkhead transcription factor, starvation, glucocorticoids, myotubes, muscle atrophy, transcriptional regulation
- MeSH terms
- Adenoviridae, Animals, Cells, Cultured, Cloning, Molecular, Fasting, Gene Expression Regulation, Genetic Vectors, Glucocorticoids, Insulin-Like Growth Factor I, Ligases, Models, Biological, Muscle Proteins, Muscular Atrophy, Promoter Regions, Genetic, Proto-Oncogene Proteins, Transcription Factors, Signal Transduction, Protein Serine-Threonine Kinases, Muscle, Skeletal, Phosphatidylinositol 3-Kinases, Muscle Cells, RNA Interference, Ubiquitin-Protein Ligases, SKP Cullin F-Box Protein Ligases, Proto-Oncogene Proteins c-akt, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
